< Back to latest news & events

Event

Webinar: How to reach ‘net zero’ by 2050?

August 2022

Event date: 21st September 2022

HGF hosted a webinar on 21st September, where Chris Goodall briefly examined the major changes that will need to take place in industries as diverse as electricity generation, steel manufacture and farming to move the UK to ‘net zero’ by 2050.

How will the world slow and then reverse the growth in greenhouse gas emissions?

The transition is not going to be simple or painless but the routes to a fully decarbonised society are now clear. This webinar will give insight into:

  • Renewable sources of power
  • Green hydrogen
  • Energy efficiency
  • Reduced utilisation of natural resources
  • ‘Circular’ economy
  • Agriculture
  • Restoration programmes for soils and trees
  • Aviation
  • Cement
  • Capturing CO2 from the air

This presentation covers all these areas, attempting to give a sense both of the scale of the challenge and the available routes to reduce emissions. Intertwined into the material are brief discussions of how much societies will be able to rely on technological improvements and how much behavioural and wider social change will be required.

Watch the webinar below:

About the speaker – Chris Goodall

Chris works on the energy transition, focusing on the technological routes which societies will use to fully decarbonise by 2050.

He is an established author, having written six books which have won awards and commendations. The most recent, What We Need To Do Now, was shortlisted for the Wainwright Prize and was one of the FT’s books of the year.

Chris is on the advisory board of Pictet Clean Energy, a $7bn investment fund in Geneva, and writes research for CLSA, a leading Asian investment bank.

He is also an active investor in young companies specialising in low carbon technologies and was chair of one of the UK’s fastest growing car charging companies before its acquisition by the French multinational Engie.

He has degrees from Cambridge, Michigan and Harvard Business School.

 

 

 

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article